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Abstract
Background: Members of the Snail gene family, which encode zinc finger proteins that function
as transcriptional repressors, play essential roles during embryonic development in vertebrates.
Mouse embryos with conditional deletion of the Snail1 (Snai1) gene in the epiblast, but not in most
extraembryonic membranes, exhibit defects in left-right asymmetry specification and migration of
mesoderm cells through the posterior primitive streak. Here we describe phenotypic defects that
result in death of the mutant embryos by 9.5 days of gestation.
Findings: Endothelial cells differentiated in epiblast-specific Snai1-deficient embryos, but formation
of an interconnected vascular network was abnormal. To determine whether the observed
vascular defects were dependent on disruption of blood flow, we analyzed vascular remodeling in
cultured allantois explants from the mutant embryos. Similar vascular defects were observed in the
mutant allantois explants.
Conclusion: These studies demonstrate that lethality in the Snai1-conditional mutant embryos is
caused by multiple defects in the cardiovascular system.
Background
In mammals, there are three Snail family genes: Snai1
(formerly  Snail),  Snai2  (formerly  Slug), and Snai3
(reviewed in [1,2]). We have shown that mouse embryos
homozygous for a Snai1 null mutation (Snai1-/- embryos)
exhibit defects in mesoderm formation and die shortly
after embryonic day (E) 7.5 [3], likely due to defects in the
extraembryonic membranes. In contrast, mouse embryos
(Meox2-Cre; Snai1flox/- embryos) with deletion of the Snai1
gene specifically in the epiblast (i.e., the embryo proper
plus extraembryonic mesoderm) survive past the period
of lethality at E7.5. These embryos exhibit defects in left-
right asymmetry specification and delayed progression of
mesoderm cells through the posterior primitive streak [4].
Here we describe phenotypic defects in Meox2-Cre;
Snai1flox/- (hereafter designated Snai1-cko) embryos that
result in death of the mutant embryos by approximately
E9-E10.
Methods
Mice
The targeted null allele of the Snai1  gene [3] and the
Snai1flox  conditional allele [5] have been described.
Snail1flox/flox  mice were maintained as homozygotes.
Meox2-Cre mice [6] were obtained from the Jackson Labo-
ratory. For the experiments described here, male mice het-
erozygous for both the Meox2-Cre allele and the Snai1 null
allele (Snai1+/-) were crossed to Snai1flox/flox females, and
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embryos were isolated at E8.5 and E9.5. Embryos of the
genotype Meox2-Cre/+; Snai1flox/- (referred to as Snai1-cko,
for  Snai1  conditional knockout) were analyzed. Litter-
mate embryos lacking one or more of the following alleles
(Meox2-Cre, Snai1flox or Snai1 null) were used as controls.
Embryos were genotyped by PCR of DNA isolated from
the yolk sac. All animal experiments were performed
under a protocol approved by the Jackson Laboratory Ani-
mal Care and Use Committee.
Allantois culture
The allantois was dissected from E8.5 mouse embryos
using tungsten needles, and was placed individually on
collagen or fibronectin-coated coverslips in 8-well culture
dishes (BD Biocoat). Explants were cultured in 0.5 ml of
culture medium (DMEM 4.5 g/l glucose, 10 mM L-
glutamine, Pen-Strep), containing 15% fetal calf serum
for 18 hours. Explants then were washed and fixed in 4%
paraformaldehyde or Methanol:DMSO (4:1) for 20 min
at room temperature and processed for immunohisto-
chemistry or TUNEL assay. For morphometric analysis of
the allantois cultures, cultures were fixed as above, immu-
nostained for PECAM-1 expression, and counterstained
with eosin. The diameter of the vascular network, as
defined by the extent of PECAM-1 positive vessels, was
measured [7]. The diameter of the underlying layer of
eosin-stained mesothelial cells was also measured. Values
were expressed as mean ± standard deviation. Differences
between the means of the mutants and controls were
tested for statistical significance using the Unpaired two-
tailed Student's t test. P values < 0.05 were considered to
be statistically significant.
Immunostaining and TUNEL analysis
For immunohistochemistry on explant cultures, fixed
cells were permeabilized and blocked in 0.1% Triton X-
100/10% goat serum/PBS for 30 minutes and incubated
for one hour with a 1:50 dilution of the corresponding
primary antibody. Antibodies included rat-monoclonal
anti-mouse CD31 (PECAM-1) (BD Biosciences Pharmin-
gen), mouse monoclonal anti-VCAM-1 (eBioscience) and
anti-mouse CD144 (VE-cadherin) (BD Biosciences
Pharmingen). Explants were washed and incubated for
one hour in the corresponding secondary antibody.
Horseradish peroxidase-coupled secondary antibodies
were from Jackson ImmunoResearch. Eosin counterstain-
ing was done after DAB (Diamino benzidine tetrahydro-
chloride) color reaction. For immunofluorescence, an
Alexa Fluor 488-labeled secondary antibody (Invitrogen)
was used, and slides were mounted with DAPI (4'-6-Dia-
midino-2-phenylindole). For TUNEL analysis, the In Situ
Cell Death Detection Kit, Fluorescein (Roche Applied Sci-
ence) was used according to the manufacturer's instruc-
tions. Optical sectioning of entire allantois explants was
performed by confocal microscopy. The complete Z series
was then collapsed and fluorescent cells per field were
counted (n = 3). Results are presented as the mean ± sem.
Statistical significance was determined using the Paired
two-tailed Student's t test, with P values < 0.05 considered
to be statistically significant.
Results
Vascular defects in mouse embryos with epiblast-specific 
deletion of the Snai1 gene
No Snai1 transcripts can be detected in Snai1-cko embryos
or allantois by E8.0 [4]. We visualized the vascular net-
work of Snai1-cko mutant embryos and littermate controls
by staining with a monoclonal antibody to platelet
endothelial cell adhesion molecule-1 (PECAM-1), a vas-
cular endothelial cell marker [8]. At E8.5, PECAM-1 posi-
tive cells were present in the Snai1-cko embryos (Fig. 1b–
d), confirming the differentiation of endothelial cells in
these embryos. Vascular defects in Snai1-cko embryos were
completely penetrant (n > 8). A primitive vascular net-
work forms in most Snai1-cko embryos, but many of these
Vascular defects in Snai1-cko embryos Figure 1
Vascular defects in Snai1-cko embryos. (a-d) PECAM-1 
immunostained E8.5 littermate control (a) and Snai1-cko (b-
d) embryos. (d) Higher magnification view of the dorsal 
region of a different embryo showing endothelial cell aggre-
gates (arrow). (e, f) VE-cadherin immunostained E8.5 control 
(e) and Snai1-cko (f) embryos. Asterisks indicate discontinu-
ous vessels, and arrows point to isolated aggregates of 
PECAM-1 positive cells.BMC Research Notes 2009, 2:22 http://www.biomedcentral.com/1756-0500/2/22
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vessels were discontinuous. The Snai1-cko embryos also
exhibited unusual aggregations of PECAM-1 positive cells
(Fig. 1b–d). Both the discontinuous vessels and the
endothelial cell aggregates were also detected in Snai1-cko
embryos immunostained for VE-cadherin (Cdh5) (Fig.
1e, f), another endothelial cell marker [9]. These results
indicated that although mesoderm cells from Snai1-cko
embryos can differentiate into endothelial cells, Snai1
function in the embryo is required for the proper morpho-
genesis of endothelial cells into a primitive capillary
plexus and for its subsequent growth and remodeling.
However, these results do not establish whether Snai1
gene function is required autonomously in the endothe-
lial cells, or nonautonomously in surrounding mesoderm
cells that also express high levels of Snai1 transcripts at
these developmental stages [10].
Snai1-cko allantois explants exhibit abnormal vascular 
morphogenesis
Our previous study of Snai1-cko  embryos had demon-
strated aberrant heart looping as the result of defects in
left-right asymmetry specification [4], which likely affects
blood flow in the mutant embryos. Since alterations in
blood flow can cause defects in vascular development and
remodeling [11], we assessed vascular development and
remodeling in Snai1-cko embryos in a situation that is not
dependent on blood flow. The embryonic allantois is a
widely utilized model system for the study of early vascu-
lar development in mice (reviewed in [12]). The allantois
contains only three known cell types (endothelial cells,
mesothelium and mesenchyme of the allantoic core), and
allantois cultures have been validated by several groups as
a powerful model for the study of the mechanisms of
blood vessel formation and remodeling [13-17].
To evaluate whether vascular defects observed in Snai1-cko
embryos may be secondary to alterations in blood flow,
we set up allantois explant cultures, in which no blood
flow occurs. Since Snai1-cko embryos at E8.5 exhibited a
shorter, bulbous allantois, before turning to the explant
culture model we sectioned PECAM-1 immunostained
allantois from Snai1-cko embryos. This analysis confirmed
that endothelial cells were present in the Snai1-cko allan-
tois (Fig. 2b). We next cultured E8.5 allantois explants on
collagen-coated plastic wells. After 18 hours of incuba-
tion, control explants exhibited a network of PECAM-1
positive capillary-like vessels (Fig. 2c). In contrast, allan-
tois explants from Snai1-cko embryos exhibited only clus-
ters of PECAM-1 positive endothelial cells that failed to
form a vascular network (Fig. 2d).
To study the response of the Snai1-cko mutant allantois
explants to other mediators of extracellular matrix adhe-
sion and to optimize culture conditions, we plated the
allantois explants on other substrates. When plated on
fibronectin-coated wells, Snai1-cko  allantois explants
formed a PECAM-1 positive network of endothelial cells,
but obvious morphological defects were evident in the
mutant explants (Fig. 3b, d). Snai1-cko explants exhibited
the accumulation of PECAM-1 positive clusters of cells
that did not completely adhere to the plate but grew up
into the culture media (Fig. 3b). Confocal images of
PECAM-1 immunofluorescent allantois cultures revealed
that control littermate allantois explants formed an inter-
connected anastomosing vascular network (Fig. 3c). In
contrast, the network formed by the Snai1-cko allantois
explants exhibited an irregular aggregation of endothelial
cells with PECAM-1 positive cells concentrated in certain
regions but absent from other large regions (Fig. 3d). To
determine whether mesothelial cells differentiated in the
allantoic explants, we assessed VCAM-1 expression. In
E8.5 control explant cultures, VCAM-1 positive cells were
Vascular morphogenesis in Snai1-cko allantois and allantois  explants plated on collagen Figure 2
Vascular morphogenesis in Snai1-cko allantois and 
allantois explants plated on collagen. (a, b) Histological 
sections of PECAM-1 immunostained E8.5 littermate control 
(a) and Snai1-cko (b) allantois. Vascular endothelial cells are 
present in both control and Snai1-cko allantois in vivo. (c, d) 
PECAM-1 immunostained allantois explants derived from 
E8.5 control (c) and Snai1-cko (d) allantoises, grown on colla-
gen. Snai1-cko explants are less expanded than control litter-
mate explants, and instead of the interconnected vascular 
network that can be seen in the littermate control explant, 
clusters of PECAM-1 positive cells that do not form a net-
work are present in the Snai1-cko explant. Scale bar in (a, b): 
20 μm; (c, d) 100 μm.BMC Research Notes 2009, 2:22 http://www.biomedcentral.com/1756-0500/2/22
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enriched in the periphery of the explant culture, and less
abundantly on top of the vascular plexus (Fig. 4b). In con-
trast, in allantoic explants from Snai1-cko  mutant
embryos, fewer VCAM-1 positive cells were detected (Fig.
4c, d), but these were also enriched in the periphery. VE-
cadherin immunostaining of control littermate allantois
explants revealed formation of an interconnected vascular
network (Fig. 4e) similar that that revealed by PECAM-1
staining (Fig. 3a). VE-cadherin immunostaining of Snai1-
cko  allantois explants revealed the presence of VE-cad-
herin-positive cells, but these cells did not form a mor-
phologically normal vascular network (Fig. 4f).
We also noted that expansion of the allantois explants was
reduced in Snai1-cko mutants. To quantify this observa-
tion, we measured the diameters of the vascular networks
in E8.5 allantois explants cultured on fibronectin [7]. The
average diameter of the vascular networks formed by lit-
termate control explants was 1.35 mm ± 0.15 (n = 12),
which was 1.4 fold greater than the average diameter
exhibited by Snai1-cko explants (0.99 mm ± 0.18; n = 9; P
< 0.05). We also measured expansion of the mesothelial
layer formed in these explants. The average diameter of
the mesothelial discs formed by control allantois explants
also was about 1.4 fold greater than those formed in
Snai1-cko  explants (1.93 mm ± 0.27 for the control
Fibronectin stimulates formation of a vascular plexus in the  Snai1-cko allantois explants Figure 3
Fibronectin stimulates formation of a vascular plexus 
in the Snai1-cko allantois explants. (a, b) PECAM-1 
immunostained allantois explants derived from E8.5 litter-
mate control (a) and Snai1-cko (b) allantoises grown on 
fibronectin. Although morphologically abnormal, formation 
of a vascular network can be observed in the Snai1-cko 
explant. Snai1-cko explants also exhibited PECAM-1 positive 
clusters of cells that did not adhere to the plate but grew up 
into the culture media. (c, d) Confocal imaging of DAPI (blue) 
and PECAM-1 (green) immunofluorescent allantois explants 
from E8.5 control (c) and Snai1-cko (d) allantoises. The Snai1-
cko explant exhibits an intense aggregation of endothelial 
cells in one region of the explant, and the absence of connec-
tions between endothelial cells in other regions. Scale bar in 
(a, b): 100 μm; (c, d) 50 μm.
VCAM1 and VE-cadherin expression in control and Snai1-cko  allantois explants Figure 4
VCAM1 and VE-cadherin expression in control and 
Snai1-cko allantois explants. (a-d) VCAM1-immunos-
tained allantois explants derived from littermate control (a, 
b) and Snai1-cko (c, d) embryos plated on fibronectin. (b) 
Higher magnification of a control explant showing that 
VCAM positive cells are more abundant in the periphery of 
the explant. In Snai1-cko mutant explants, fewer VCAM1-pos-
itive cells are observed, but these cells also tend to localize 
to the periphery of the explant. (e, f) VE-cadherin-immunos-
tained allantois explants derived from E8.5 control (e) and 
Snai1-cko (f) embryos. Scale bar (a, c-f): 100 μm, (b) 50 μm.BMC Research Notes 2009, 2:22 http://www.biomedcentral.com/1756-0500/2/22
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explants versus 1.39 mm ± 0.24 for the mutant explants;
P < 0.05).
Apoptosis is increased in Snai1-cko allantois explants
The Snai1 and Snai2 genes have a demonstrated role in the
protection of cells from apoptotic cell death [18-23]. We
assessed apoptotic cell death in allantois explants by
TUNEL assay. Snai1-cko  explants exhibited an obvious
increase in the number of fluorescent cells (Fig. 5b). To
quantify this observation, TUNEL-positive fluorescent
cells were counted in one field of a complete Z series col-
lapsed from confocal images. In littermate control
explants, a mean of 161 ± 18 (n = 3) TUNEL-positive cells
per field were present, while in the Snai1-cko explants a
mean of 284 ± 25 (n = 3) TUNEL-positive cells per field
were present (Fig. 5c). This difference represented a 76%
increase of TUNEL-positive cells in the Snai1-cko mutant
explants compared to the controls (P  < 0.05). Further
work will be required to determine the mechanism by
which loss of Snai1 function in the allantois cultures from
Snai1-cko embryos leads to an increase in cell death.
Discussion
Taken together, our results demonstrate that the cause of
death of Snai1-cko embryos at E9-E10 is multiple cardio-
vascular defects (i.e., heart looping defects, vascular mor-
phogenesis and remodeling defects, and failure of
allantois-chorion fusion). In Snai1-cko embryos, angiob-
last differentiation into endothelial cells occurred, but
morphogenesis into an interconnected vascular network
was defective. The observation of vascular defects in the
allantois cultures, in which no circulation occurs, demon-
strates that at least some of the vascular defects observed
in  Snai1-cko  embryos are not secondary to defects in
blood flow. Vascular network formation by Snai1-cko
allantois cultures was better on fibronectin than on colla-
gen, although network formation was much worse than
that of littermate control cultures on both substrates.
Recent work has demonstrated that Snai1 over-expression
in epithelial cell lines can regulate expression of integrins
and laminins [24]. Snai1 over-expression also enhanced
the ability of these cells to attach to a fibronectin-coated
substratum. These results are consistent with our finding
that Snai1-cko cells do not adhere as well as control litter-
mate cells to fibronectin (Fig. 3).
We do not know at present whether Snai1  function is
required autonomously within endothelial cells, or is
required nonautonomously in the surrounding tissues.
Due to the strong and widespread expression of Snai1
RNA during early mouse embryogenesis [10], plus the
lack of a good anti-SNAI1 antibody, we have not been
able to determine unequivocally whether the Snai1 gene
is expressed in endothelial cells in vivo during early stages
of postimplantation mouse development (e.g., days E8-
E10 of gestation). However, the Snai1 gene is expressed at
similar stages in endocardial cells of the heart [25], which
are functionally similar to endothelial cells. SNAI1 pro-
tein also is expressed in human umbilical vein endothelial
cells [26], and Snai1 RNA is expressed in endothelial cells
purified from differentiated mouse embryonic stem cells
[26]. These data suggest the likely possibility that Snai1
gene function is required autonomously in endothelial
cells.
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